Caribou Biosciences, Inc. (CRBU) Net margin 2019–2025
Caribou Biosciences, Inc. (CRBU) net profit margin by fiscal year — reported net income divided by reported revenue.
-1327.4%FY2025 · since FY2019: -404.8% → -1327.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1327.4% | +164.5 pp |
| FY2024 | -1491.9% | -1195.9 pp |
| FY2023 | -296.1% | +421.7 pp |
| FY2022 | -717.8% | -20.5 pp |
| FY2021 | -697.3% | -419.7 pp |
| FY2020 | -277.6% | +127.3 pp |
| FY2019 | -404.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice